Seamus Mulligan, Director at Jazz Pharmaceuticals plc (JAZZ), sold 27,968 shares at $128.97 ($3.6M) on 2016-08-25, disclosed to the SEC on 2016-08-26.
Seasonal sale ($3.6M) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.65 | 3,565 | $452K | 12.6% |
| 2 | $127.70 | 9,500 | $1.2M | 33.8% |
| 3 | $128.97 | 10,283 | $1.3M | 37.0% |
| 4 | $129.42 | 4,620 | $598K | 16.7% |
| Total | $128.32 avg | 27,968 | $3.6M | 100% |
| Filing → |
| JAZZ | BUY | 2018-11-19 | $14.2M | — | Filing → |
| JAZZ | SELL | 2016-08-26 | $6.0M | — | Filing → |
| JAZZ | SELL | 2016-08-26 | $2.3M | — | Filing → |